Tag Archive for: machine learning

Accelerating and derisking antibody drug development by early lead panel optimization. Picture:©Yumab GmbH

Antibody engineering?The development of therapeutic antibodies is a time and cost ­intensive process. Biological and physicochemical properties of the lead molecules ­influence almost every step in the development. Investing into antibody engineering and lead ­optimisation during early development pays off in later steps and does not only accelerate the programme, but also increases the chance of success.

eb_2017_autumn_cancerdive1.jpg

As Big Data analytics begin to inspire medical decisionmaking, companies and scientists have gone to war over access to data derived from patient biopsies. Cancer profiling is a seminal situation. While some companies are seeking to profit from approaches to advanced mutation analysis, researchers are vociferous in demanding open access to proprietary data­bases behind company firewalls.